Shoreline Biosciences is a biomedical company intended to establish immunotherapies for seriously ill patients.
Shoreline Biosciences has raised $140.0M in total funding. The most recent round was Series B. The last funding was announced in November 2021.
Shoreline Biosciences's investors include Janus Henderson Investors, Cormorant Asset Management, Commodore Capital, BeiGene, Irving Investors.
Shoreline Biosciences is headquartered in La Jolla, United States.
Shoreline Biosciences is a biomedical company intended to establish immunotherapies for seriously ill patients.
Shoreline Biosciences is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Shoreline Biosciences — Funding & Investors." VCBacked, November 2, 2021, https://www.vcbacked.co/company/shoreline-biosciences. Accessed August 14, 2026.
VCBacked. (2021). Shoreline Biosciences — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/shoreline-biosciences
{{cite web |title=Shoreline Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/shoreline-biosciences |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated